These results are in line with a previous report on stage I lung adenocarcinoma which found that CD14+ and CD16+ monocyte numbers are decreased at the tumor site, express less HLA-DR than macrophages and secreted less IL-8 and IL-1β at the tumor site compared to monocytes at the rest of the tissue (131). The gene discussed is CD14; the disease is neoplasm.